Literature DB >> 27076173

Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots.

Olga Sala Torra1, Lan Beppu1, Jordan L Smith1, Linda Welden2, Jasmina Georgievski2, Karisma Gupta1, Rashmi Kumar1, Cecilia C S Yeung3, Amy Paguirigan1, Ted A Gooley1, Susan Branford4, Jerald P Radich1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27076173      PMCID: PMC4891957          DOI: 10.1182/blood-2015-12-689059

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

1.  RNA analysis from newborn screening dried blood specimens.

Authors:  Y H Zhang; E R McCabe
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

2.  Dried blood spot on filter paper as a source of mRNA.

Authors:  Y Matsubara; H Ikeda; H Endo; K Narisawa
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

3.  Blood on filter paper as a readily available source of bcr-abl rearranged mRNA.

Authors:  M Suttorp; M Ritgen; N von Neuhoff; R Schoch; N Schmitz
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

4.  Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ assay on dried blood spots.

Authors:  R R Lilian; K Bhowan; G G Sherman
Journal:  J Clin Virol       Date:  2010-03-07       Impact factor: 3.168

5.  In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.

Authors:  Joseph L Wiemels; Zhijian Xiao; Patricia A Buffler; Ana T Maia; Xiaomei Ma; Brian M Dicks; Martyn T Smith; Luoping Zhang; James Feusner; John Wiencke; Kathy Pritchard-Jones; Helena Kempski; Mel Greaves
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  Prenatal origin of acute lymphoblastic leukaemia in children.

Authors:  J L Wiemels; G Cazzaniga; M Daniotti; O B Eden; G M Addison; G Masera; V Saha; A Biondi; M F Greaves
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

7.  Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia.

Authors:  T Yagi; S Hibi; Y Tabata; K Kuriyama; T Teramura; T Hashida; Y Shimizu; T Takimoto; S Todo; T Sawada; S Imashuku
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

8.  Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia.

Authors:  K Fasching; S Panzer; O A Haas; R Marschalek; H Gadner; E R Panzer-Grümayer
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

9.  Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability.

Authors:  Don Brambilla; Cheryl Jennings; Grace Aldrovandi; James Bremer; Anne Marie Comeau; Sharon A Cassol; Ruth Dickover; J Brooks Jackson; Jane Pitt; John L Sullivan; Ann Butcher; Lynell Grosso; Patricia Reichelderfer; Susan A Fiscus
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities.

Authors:  Sarah M Lofgren; Anne B Morrissey; Caroline C Chevallier; Anangisye I Malabeja; Sally Edmonds; Ben Amos; David J Sifuna; Lorenz von Seidlein; Werner Schimana; Wendy S Stevens; John A Bartlett; John A Crump
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

View more
  7 in total

1.  Robustness of comprehensive DNA- and RNA-based assays at diagnosis of acute myeloid leukemia using blood and bone marrow stored on filter cards.

Authors:  T Haferlach; S Weber; R Konietschke; N Nadarajah; A Stengel; W Kern; C Haferlach; M Meggendorfer
Journal:  Leukemia       Date:  2016-05-25       Impact factor: 11.528

2.  Meeting the needs of CML patients in resource-poor countries.

Authors:  Hemant Malhotra; Jerald Radich; Pat Garcia-Gonzalez
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Molecular monitoring in chronic myeloid leukemia-how low can you go?

Authors:  Susan Branford
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 4.  Precision Medicine in Low- and Middle-Income Countries.

Authors:  Jerald P Radich; Edward Briercheck; Daniel T Chiu; Manoj P Menon; Olga Sala Torra; Cecilia C S Yeung; Edus H Warren
Journal:  Annu Rev Pathol       Date:  2022-01-24       Impact factor: 32.350

Review 5.  Current developments in molecular monitoring in chronic myeloid leukemia.

Authors:  Justine Ellen Marum; Susan Branford
Journal:  Ther Adv Hematol       Date:  2016-07-15

Review 6.  Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances.

Authors:  Cosimo Cumbo; Luisa Anelli; Giorgina Specchia; Francesco Albano
Journal:  Cancer Manag Res       Date:  2020-05-06       Impact factor: 3.989

Review 7.  Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.

Authors:  Luis Antonio Meillon-Garcia; Roberta Demichelis-Gómez
Journal:  Curr Oncol Rep       Date:  2020-10-06       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.